Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chris Jones

Showing results (261-270 of 333) with videos related to

Pageof 34
Sort By:
Biorxiv : the Preprint Server for Biology|March 3, 2023
Cooperativity between H3.3K27M and PDGFRA poses multiple therapeutic vulnerabilities in human iPSC-derived diffuse midline glioma avatarsKasey R Skinner, Tomoyuki Koga, Shunichiro Miki, et al.
Cell & Bioscience|November 14, 2023
Inhibition of exosome biogenesis affects cell motility in heterogeneous sub-populations of paediatric-type diffuse high-grade gliomasGiulia Pericoli, Angela Galardi, Alessandro Paolini, et al.
Journal of Neuro-Oncology|May 16, 2016
Pseudoprogression in children, adolescents and young adults with non-brainstem high grade glioma and diffuse intrinsic pontine gliomaFernando Carceller, Lucy A Fowkes, Komel Khabra, et al.
Science Translational Medicine|March 4, 2016
ATRX loss promotes tumor growth and impairs nonhomologous end joining DNA repair in gliomaCarl Koschmann, Anda-Alexandra Calinescu, Felipe J Nunez, et al.
Wellcome Open Research|August 19, 2021
Strategic treatment optimization for HCV (STOPHCV1): a randomised controlled trial of ultrashort duration therapy for chronic hepatitis CGraham S Cooke, Sarah Pett, Leanne McCabe, et al.
Oncotarget|January 18, 2018
Development of a targeted sequencing approach to identify prognostic, predictive and diagnostic markers in paediatric solid tumoursElisa Izquierdo, Lina Yuan, Sally George, et al.
Plos Genetics|May 10, 2014
Population genomic analysis of ancient and modern genomes yields new insights into the genetic ancestry of the Tyrolean Iceman and the genetic structure of EuropeMartin Sikora, Meredith L Carpenter, Andres Moreno-Estrada, et al.
Journal of Medicinal Chemistry|August 17, 2016
Optimization of a Series of Bivalent Triazolopyridazine Based Bromodomain and Extraterminal Inhibitors: The Discovery of (3R)-4-[2-[4-[1-(3-Methoxy-[1,2,4]triazolo[4,3-b]pyridazin-6-yl)-4-piperidyl]phenoxy]ethyl]-1,3-dimethyl-piperazin-2-one (AZD5153)Robert H Bradbury, Rowena Callis, Gregory R Carr, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 16, 2021
Correction to: Molecular landscape of IDH-mutant primary astrocytoma Grade IV/GlioblastomasQueenie Hoi-Wing Wong, Kay Ka-Wai Li, Wei-Wei Wang, et al.
Communications Biology|May 18, 2019
ALK2 inhibitors display beneficial effects in preclinical models of <i>ACVR1</i> mutant diffuse intrinsic pontine gliomaDiana Carvalho, Kathryn R Taylor, Nagore Gene Olaciregui, et al.
Pageof 34

Showing results (261-270 of 333) with videos related to

Sort By:
Pageof 34
Biorxiv : the Preprint Server for Biology|March 3, 2023
Cooperativity between H3.3K27M and PDGFRA poses multiple therapeutic vulnerabilities in human iPSC-derived diffuse midline glioma avatarsKasey R Skinner, Tomoyuki Koga, Shunichiro Miki, et al.
Cell & Bioscience|November 14, 2023
Inhibition of exosome biogenesis affects cell motility in heterogeneous sub-populations of paediatric-type diffuse high-grade gliomasGiulia Pericoli, Angela Galardi, Alessandro Paolini, et al.
Journal of Neuro-Oncology|May 16, 2016
Pseudoprogression in children, adolescents and young adults with non-brainstem high grade glioma and diffuse intrinsic pontine gliomaFernando Carceller, Lucy A Fowkes, Komel Khabra, et al.
Science Translational Medicine|March 4, 2016
ATRX loss promotes tumor growth and impairs nonhomologous end joining DNA repair in gliomaCarl Koschmann, Anda-Alexandra Calinescu, Felipe J Nunez, et al.
Wellcome Open Research|August 19, 2021
Strategic treatment optimization for HCV (STOPHCV1): a randomised controlled trial of ultrashort duration therapy for chronic hepatitis CGraham S Cooke, Sarah Pett, Leanne McCabe, et al.
Oncotarget|January 18, 2018
Development of a targeted sequencing approach to identify prognostic, predictive and diagnostic markers in paediatric solid tumoursElisa Izquierdo, Lina Yuan, Sally George, et al.
Plos Genetics|May 10, 2014
Population genomic analysis of ancient and modern genomes yields new insights into the genetic ancestry of the Tyrolean Iceman and the genetic structure of EuropeMartin Sikora, Meredith L Carpenter, Andres Moreno-Estrada, et al.
Journal of Medicinal Chemistry|August 17, 2016
Optimization of a Series of Bivalent Triazolopyridazine Based Bromodomain and Extraterminal Inhibitors: The Discovery of (3R)-4-[2-[4-[1-(3-Methoxy-[1,2,4]triazolo[4,3-b]pyridazin-6-yl)-4-piperidyl]phenoxy]ethyl]-1,3-dimethyl-piperazin-2-one (AZD5153)Robert H Bradbury, Rowena Callis, Gregory R Carr, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 16, 2021
Correction to: Molecular landscape of IDH-mutant primary astrocytoma Grade IV/GlioblastomasQueenie Hoi-Wing Wong, Kay Ka-Wai Li, Wei-Wei Wang, et al.
Communications Biology|May 18, 2019
ALK2 inhibitors display beneficial effects in preclinical models of <i>ACVR1</i> mutant diffuse intrinsic pontine gliomaDiana Carvalho, Kathryn R Taylor, Nagore Gene Olaciregui, et al.
Pageof 34